SNSE Short Interest

Sensei Biotherapeutics, Inc. (SNSE) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $18.6M, listed on NASDAQ, employing roughly 14 people, carrying a beta of -0.23 to the broader market. Sensei Biotherapeutics, Inc. Led by Christopher W. Gerry, public since 2021-02-04.

Short interest is the total number of shares currently sold short and not yet covered, reported bi-monthly by FINRA. Days to cover (short interest divided by average daily volume) indicates how long it would take short sellers to close positions, with higher values signaling greater squeeze potential.

Settlement Date
2026-06-15
Short Interest
615.4K
Previous Short Interest
798.3K
Change
-22.91%
Days to Cover
9.11
Avg Daily Volume
67.6K
Avg Days to Cover (24 reports)
5.86

Showing 24 bi-monthly FINRA short interest reports for Sensei Biotherapeutics, Inc..

Learn how short interest is reported and how to read the data →